Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cdk14 | Rat | 1,2-dichloroethane | affects expression | ISO | Cdk14 (Mus musculus) | 6480464 | ethylene dichloride affects the expression of CDK14 mRNA | CTD | PMID:28960355 | Cdk14 | Rat | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of CDK14 mRNA | CTD | PMID:21983209 | Cdk14 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CDK14 mRNA | CTD | PMID:17942748 | Cdk14 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA | CTD | PMID:17942748 | Cdk14 | Rat | 17beta-estradiol | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of CDK14 mRNA | CTD | PMID:30165855 | Cdk14 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA | CTD | PMID:17942748 | Cdk14 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK14 mRNA | CTD | PMID:32109520|PMID:33387578 | Cdk14 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cdk14 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CDK14 mRNA | CTD | PMID:24680724 | Cdk14 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDK14 mRNA | CTD | PMID:32109520 | Cdk14 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cdk14 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of CDK14 mRNA | CTD | PMID:38648751 | Cdk14 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CDK14 mRNA | CTD | PMID:20188158 | Cdk14 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDK14 mRNA | CTD | PMID:30071829 | Cdk14 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Cdk14 | Rat | 3-Nitrobenzanthrone | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | 3-nitrobenzanthrone results in decreased expression of CDK14 mRNA | CTD | PMID:34036453 | Cdk14 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Cdk14 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Cdk14 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CDK14 gene | CTD | PMID:31683443 | Cdk14 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CDK14 mRNA | CTD | PMID:28973697 | Cdk14 | Rat | 4-nitrophenol | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | 4-nitrophenol results in increased expression of CDK14 mRNA | CTD | PMID:34673133 | Cdk14 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CDK14 mRNA | CTD | PMID:22504374 | Cdk14 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of CDK14 mRNA | CTD | PMID:28959563 | Cdk14 | Rat | aflatoxin B1 | affects expression | ISO | CDK14 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CDK14 protein | CTD | PMID:20106945 | Cdk14 | Rat | aflatoxin B1 | decreases methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CDK14 gene | CTD | PMID:27153756 | Cdk14 | Rat | aflatoxin B1 | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CDK14 mRNA | CTD | PMID:22100608 | Cdk14 | Rat | aldrin | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Aldrin results in increased expression of CDK14 mRNA | CTD | PMID:18579281 | Cdk14 | Rat | all-trans-retinoic acid | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CDK14 mRNA | CTD | PMID:21934132 | Cdk14 | Rat | all-trans-retinoic acid | increases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CDK14 mRNA | CTD | PMID:33167477 | Cdk14 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CDK14 mRNA | CTD | PMID:38685447 | Cdk14 | Rat | antirheumatic drug | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CDK14 mRNA | CTD | PMID:24449571 | Cdk14 | Rat | aristolochic acid A | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CDK14 mRNA | CTD | PMID:33212167 | Cdk14 | Rat | arsenite(3-) | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA | CTD | PMID:15894712 | Cdk14 | Rat | arsenite(3-) | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CDK14 mRNA] | CTD | PMID:32406909 | Cdk14 | Rat | arsenite(3-) | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | arsenite results in increased expression of CDK14 mRNA | CTD | PMID:15894712 | Cdk14 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CDK14 gene | CTD | PMID:28931070 | Cdk14 | Rat | benzene | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Benzene results in increased expression of CDK14 mRNA | CTD | PMID:37084897 | Cdk14 | Rat | benzo[a]pyrene | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA | CTD | PMID:15894712 | Cdk14 | Rat | benzo[a]pyrene | affects methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CDK14 3' UTR; Benzo(a)pyrene affects the methylation of CDK14 intron; more ... | CTD | PMID:27901495|PMID:30157460 | Cdk14 | Rat | benzo[a]pyrene | increases methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CDK14 exon | CTD | PMID:27901495 | Cdk14 | Rat | benzo[a]pyrene | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CDK14 mRNA | CTD | PMID:20064835|PMID:20106945|PMID:22316170 | Cdk14 | Rat | benzo[a]pyrene | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CDK14 mRNA | CTD | PMID:15894712|PMID:21569818 | Cdk14 | Rat | benzo[e]pyrene | affects methylation | ISO | CDK14 (Homo sapiens) | 6480464 | benzo(e)pyrene affects the methylation of CDK14 intron | CTD | PMID:30157460 | Cdk14 | Rat | bis(2-chloroethyl) sulfide | affects expression | EXP | | 6480464 | Mustard Gas affects the expression of CDK14 mRNA | CTD | PMID:15651846 | Cdk14 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CDK14 mRNA | CTD | PMID:33754040 | Cdk14 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CDK14 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:34947998 | Cdk14 | Rat | bisphenol A | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CDK14 mRNA | CTD | PMID:35598803 | Cdk14 | Rat | bisphenol A | affects methylation | ISO | CDK14 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of CDK14 gene | CTD | PMID:31601247 | Cdk14 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDK14 mRNA | CTD | PMID:32145629 | Cdk14 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of CDK14 mRNA | CTD | PMID:19167457 | Cdk14 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CDK14 mRNA | CTD | PMID:33453195 | Cdk14 | Rat | carbon nanotube | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of CDK14 mRNA | CTD | PMID:25554681 | Cdk14 | Rat | CGP 52608 | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CDK14 gene] | CTD | PMID:28238834 | Cdk14 | Rat | chlorpyrifos | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CDK14 mRNA | CTD | PMID:37019170 | Cdk14 | Rat | choline | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cdk14 | Rat | chrysene | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | chrysene results in decreased expression of CDK14 mRNA | CTD | PMID:26377693 | Cdk14 | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CDK14 mRNA | CTD | PMID:22023808 | Cdk14 | Rat | cisplatin | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of CDK14 mRNA | CTD | PMID:27392435 | Cdk14 | Rat | coumarin | increases phosphorylation | ISO | CDK14 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of CDK14 protein | CTD | PMID:35688186 | Cdk14 | Rat | crocidolite asbestos | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of CDK14 mRNA | CTD | PMID:29279043 | Cdk14 | Rat | cyclosporin A | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CDK14 mRNA | CTD | PMID:22147139|PMID:27989131 | Cdk14 | Rat | cyclosporin A | decreases methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of CDK14 promoter | CTD | PMID:27989131 | Cdk14 | Rat | DDE | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of CDK14 mRNA | CTD | PMID:38568856 | Cdk14 | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of CDK14 mRNA | CTD | PMID:23914054 | Cdk14 | Rat | dexamethasone | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Cdk14 | Rat | Dibutyl phosphate | affects expression | ISO | CDK14 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CDK14 mRNA | CTD | PMID:37042841 | Cdk14 | Rat | dioxygen | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA | CTD | PMID:30529165 | Cdk14 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of CDK14 mRNA | CTD | PMID:29391264 | Cdk14 | Rat | epoxiconazole | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CDK14 mRNA | CTD | PMID:35436446 | Cdk14 | Rat | ethanol | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of CDK14 mRNA | CTD | PMID:30319688 | Cdk14 | Rat | folic acid | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cdk14 | Rat | formaldehyde | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CDK14 mRNA | CTD | PMID:23649840 | Cdk14 | Rat | geldanamycin | increases expression | ISO | CDK14 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of CDK14 mRNA | CTD | PMID:26705709 | Cdk14 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CDK14 mRNA | CTD | PMID:33387578 | Cdk14 | Rat | indometacin | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Cdk14 | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of CDK14 mRNA | CTD | PMID:20080153 | Cdk14 | Rat | L-methionine | multiple interactions | ISO | Cdk14 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Cdk14 | Rat | mercury dichloride | increases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Mercuric Chloride results in increased expression of CDK14 mRNA | CTD | PMID:27188386 | Cdk14 | Rat | mercury dichloride | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased expression of CDK14 mRNA | CTD | PMID:27188386 | Cdk14 | Rat | methapyrilene | affects methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Methapyrilene affects the methylation of CDK14 intron | CTD | PMID:30157460 | Cdk14 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of CDK14 mRNA | CTD | PMID:22504374 | Cdk14 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of CDK14 gene | CTD | PMID:35440735 | Cdk14 | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of CDK14 gene | CTD | PMID:33148267 | Cdk14 | Rat | nickel sulfate | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of CDK14 mRNA | CTD | PMID:22714537 | Cdk14 | Rat | O-methyleugenol | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of CDK14 mRNA | CTD | PMID:32234424 | Cdk14 | Rat | ochratoxin A | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of CDK14 mRNA | CTD | PMID:29098329 | Cdk14 | Rat | ochratoxin A | decreases acetylation | ISO | CDK14 (Homo sapiens) | 6480464 | ochratoxin A results in decreased acetylation of CDK14 promoter | CTD | PMID:29098329 | Cdk14 | Rat | ochratoxin A | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of more ... | CTD | PMID:29098329 | Cdk14 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA | CTD | PMID:25729387 | Cdk14 | Rat | ozone | multiple interactions | ISO | CDK14 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CDK14 mRNA | CTD | PMID:35430440 | Cdk14 | Rat | paracetamol | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CDK14 mRNA | CTD | PMID:21420995 | Cdk14 | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of CDK14 gene | CTD | PMID:33148267 | Cdk14 | Rat | phenylarsine oxide | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | oxophenylarsine results in increased expression of CDK14 mRNA | CTD | PMID:37699712 | Cdk14 | Rat | potassium chromate | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CDK14 mRNA | CTD | PMID:22714537 | Cdk14 | Rat | sodium arsenite | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CDK14 mRNA | CTD | PMID:34032870 | Cdk14 | Rat | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of CDK14 mRNA | CTD | PMID:22110744 | Cdk14 | Rat | temozolomide | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of CDK14 mRNA | CTD | PMID:31758290 | Cdk14 | Rat | tetrachloromethane | affects expression | ISO | Cdk14 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of CDK14 mRNA | CTD | PMID:17484886 | Cdk14 | Rat | thimerosal | affects expression | ISO | CDK14 (Homo sapiens) | 6480464 | Thimerosal affects the expression of CDK14 mRNA | CTD | PMID:27188386 | Cdk14 | Rat | titanium dioxide | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CDK14 mRNA | CTD | PMID:35295148 | Cdk14 | Rat | titanium dioxide | decreases methylation | ISO | Cdk14 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CDK14 gene | CTD | PMID:35295148 | Cdk14 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA | CTD | PMID:25729387 | Cdk14 | Rat | torcetrapib | increases expression | ISO | CDK14 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of CDK14 mRNA | CTD | PMID:23228038 | Cdk14 | Rat | trichostatin A | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CDK14 mRNA | CTD | PMID:26272509 | Cdk14 | Rat | triphenyl phosphate | decreases expression | EXP | | 6480464 | triphenyl phosphate results in decreased expression of CDK14 mRNA | CTD | PMID:30589522 | Cdk14 | Rat | triptonide | decreases expression | ISO | Cdk14 (Mus musculus) | 6480464 | triptonide results in decreased expression of CDK14 mRNA | CTD | PMID:33045310 | Cdk14 | Rat | valproic acid | decreases methylation | ISO | CDK14 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CDK14 gene | CTD | PMID:29154799 | Cdk14 | Rat | valproic acid | affects expression | ISO | CDK14 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CDK14 mRNA | CTD | PMID:25979313 | Cdk14 | Rat | valproic acid | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CDK14 mRNA | CTD | PMID:26272509 | Cdk14 | Rat | vorinostat | decreases expression | ISO | CDK14 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of CDK14 mRNA | CTD | PMID:27188386 | Cdk14 | Rat | WIN 55212-2 | increases expression | ISO | Cdk14 (Mus musculus) | 6480464 | (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of CDK14 mRNA | CTD | PMID:12237329 | |






















